Cladis Investment Advisory, LLC
Source: SEC Form 13F · as of Mar 2026Cladis Investment Advisory, LLC holds 15 biotech & pharma companies tracked by BioSniper, totaling $13.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
15
Total value held
$13.9M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 4,142 | $3.8M |
| PFEPFIZER INC | 62,048 | $1.7M |
| MRKMerck & Co., Inc. | 14,124 | $1.7M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 5,269 | $1.4M |
| GEHCGE HealthCare Technologies Inc. | 17,168 | $1.2M |
| BMYBRISTOL MYERS SQUIBB CO | 15,300 | $928K |
| JNJJOHNSON & JOHNSON | 3,650 | $892K |
| PMPhilip Morris International Inc | 2,209 | $365K |
| ABBVAbbVie Inc. | 1,558 | $339K |
| PTCTPTC THERAPEUTICS, INC. | 4,200 | $286K |
| AMGNAMGEN INC | 715 | $252K |
| CPRXCATALYST PHARMACEUTICALS, INC. | 10,020 | $248K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 542 | $242K |
| GMOptec International, Inc. | 3,248 | $242K |
| NVONovo Nordisk A/S | 5,700 | $209K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.